Abivax - The Next $15 Billion Buyout
Published March 19, 2026
Views 450 | Likes 19 | Comments 10
At a glance
Views
450
Likes
19
Comments
10
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Is Abivax (ABVX) the next big multibagger in the biotech sector? In today’s deep dive, we’re breaking down the massive potential of Abivax and its lead drug candidate, obefazimod, following its game-changing Phase 3 clinical data. AstraZeneca looks to be a potential bidder. As the Inflammatory Bowel Disease (IBD) ma…
- Published
- March 19, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.